Vanguard Personalized Indexing Management’s Neumora Therapeutics NMRA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio NMRA Stock Details NMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$121K	Sell	62,032 -2,871	-4%	-$7.44K	﹤0.01%	1926
2025 Q4	$116K	Buy	64,903 +474	+0.7%	+$1.04K	﹤0.01%	1792
2025 Q3	$117K	Buy	64,429 +6,233	+11%	+$10.1K	﹤0.01%	1793
2025 Q2	$42.7K	Buy	58,196 +32,922	+130%	+$24.9K	﹤0.01%	1849
2025 Q1	$25.3K	Buy	+25,274	New	+$43.3K	﹤0.01%	1748

Other funds holding NMRA

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return